Unless otherwise required by applicable law, the Policy will not be subject to approval by the Company’s stockholders, including, for the avoidance of doubt, as a result of or in connection with an action taken with respect to this Policy as contemplated in Section 9.

Stockholder Approval. The Company will obtain stockholder approval of any Plan amendment to the extent necessary and desirable to comply with Applicable Laws.

Stockholder Approval. The Plan will be subject to approval by the stockholders of the Company within twelve (12) months after the date the Plan is adopted by the Board. Such stockholder approval will be obtained in the manner and to the degree required under Applicable Laws.

Stockholder Approval. Eastside will use commercially reasonable efforts to obtain from its stockholders as soon as possible following the date hereof such approval as is required by applicable law and/or rules of the Trading Market to effect all material terms of this Agreement (the “Stockholder Approval”), including without limitation approval to amend its articles of incorporation to increase its authorized Common Stock to a number of shares that equals or exceeds ten million (10,000,000) shares.

Stockholder Approval. Notwithstanding anything herein to the contrary, to the extent that the Award exceeds the applicable individual award limit(s) set forth in [Section 3(b)] of the Plan (the “Excess Award”), the Excess Award shall be subject to approval by the Company’s stockholders of an amendment to the Plan increasing the individual award limit(s) set forth in [Section 3(b)] of the Plan (the “Plan Amendment”). Notwithstanding anything herein to the contrary, neither the Excess Award nor the Performance Units attributable thereto shall be paid to any extent prior to the time when the Plan Amendment is approved by the stockholders, and if such approval is not obtained at the next annual meeting of the Company’s stockholders following the Award Date (or by December 4, 2016, if earlier), the Excess Award and the Performance Units attributable thereto shall thereupon automatically be cancelled and become null and void. The Participant acknowledges that the Excess Award and the Performance Units attributable thereto are being granted prior to approval by the Company’s stockholders of the Plan Amendment.

Effective Date and Stockholder Approval. The Plan was originally adopted by National Western Life Insurance Company effective as of June 20, 2008. The Plan was then amended and restated effective as of June 17, 2011 after its approval by the Board effective as of such date and its approval by the Stockholders at the Annual Meeting of Stockholders held on such date. The Plan and all Awards were assumed by the Company effective October 1, 2015 in connection with the holding company reorganization of National Western Life Insurance Company and its subsidiaries. The Plan, as amended and restated herein, shall be effective as of December 14, 2022. Notwithstanding the foregoing, for purposes of establishing the ten (10)-year period during which the Plan shall remain in effect, the effective date with respect to the prior amendment and restatement dated, June 15, 2016 shall apply (i.e., after its approval by the Board effective as of such date and its approval by the Stockholders at the Annual Meeting of Stockholders held on such date). For purposes of this Plan, including this Section and Sections 14.1 and 14.2, any such Stockholder approval shall be considered obtained if such approval complies with # all applicable provisions of the articles of incorporation and bylaws of the Company and applicable state law prescribing the method and degree of stockholder approval required for the issuance of corporate stock or stock options (and if applicable state law does not prescribe such method and degree of stockholder approval, such approval must otherwise be obtained in accordance with Code section 422) and # any applicable listing requirements of Nasdaq to the extent the Company is subject to such requirements.

Efforts. During the term of employment, Employee shall devote his or her full-time business efforts to the performance of Employee’s duties and the furtherance of the Company’s interests as well as the interests of the Company’s parent-company, Forward Industries, Inc. and its subsidiaries (collectively, the “Parent”).

services in support of Therapeutics’ efforts to successfully obtain FDA Approval for the Drug Product described in [Schedule I] hereto; and

if the approval of the holders of the Company Common Stock is sought to effectuate any component of the Transactions, including any stockholder approval required under NYSE Rule 312.03 in connection with the issuance of the Conversion Shares (the “Stockholder Approval”), it shall vote all Company Common Stock that it beneficially owns to approve such actions, and take such other and further actions with respect to such Company Common Stock as are reasonably necessary or appropriate to obtain approval of the Transactions;

Approval. This Agreement is subject to prior review and approval of the Compensation Committee of the Company’s Board.